Baumer S.A. (BVMF:BALM3)
Brazil
· Delayed Price · Currency is BRL 16.30
+0.34 (2.13%)
May 12, 2025, 2:19 PM GMT-3
Baumer Revenue
Baumer had revenue of 49.26M BRL in the quarter ending March 31, 2025, with 35.62% growth. This brings the company's revenue in the last twelve months to 207.32M, up 23.74% year-over-year. In the year 2024, Baumer had annual revenue of 194.39M with 14.38% growth.
Revenue (ttm)
207.32M
Revenue Growth
+23.74%
P/S Ratio
0.78
Revenue / Employee
677.53K
Employees
306
Market Cap
161.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 194.39M | 24.44M | 14.38% |
| Dec 31, 2023 | 169.95M | 5.41M | 3.29% |
| Dec 31, 2022 | 164.54M | 30.72M | 22.96% |
| Dec 31, 2021 | 133.82M | -29.15M | -17.89% |
| Dec 31, 2020 | 162.97M | 13.66M | 9.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 51.35B |
| Raia Drogasil | 39.81B |
| Hypera | 6.70B |
| Fleury | 7.80B |
| Odontoprev | 2.46B |
| Oncoclínicas do Brasil Serviços Médicos | 6.26B |
| Blau Farmacêutica | 1.77B |
| Empreendimentos Pague Menos | 13.13B |